BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 10341871)

  • 21. [Bystander effect mediated by herpes simplex virus-thymidine kinase/ganciclovir approach on prostatic cancer cells and its regulation].
    Xing Y; Lu G; Xiao Y; Zeng F; Zhang Q; Xiong P; Feng W
    Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(21):1484-7. PubMed ID: 12509912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced effect of microdystrophin gene transfection by HSV-VP22 mediated intercellular protein transport.
    Xiong F; Xiao S; Yu M; Li W; Zheng H; Shang Y; Peng F; Zhao C; Zhou W; Chen H; Fang L; Chamberlain JS; Zhang C
    BMC Neurosci; 2007 Jul; 8():50. PubMed ID: 17617925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of lentivirus-mediated and MUC1 antibody-targeted VP22-TK/GCV suicide gene therapy for ovarian cancer.
    Kong B; Wang W; Liu C; Song L; Ma D; Qu X; Jiang J; Yang X; Zhang Y; Wang B; Wei MQ; Yang Q
    In Vivo; 2003; 17(2):153-6. PubMed ID: 12792977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adenovirus-mediated gene transfer of enhanced Herpes simplex virus thymidine kinase mutants improves prodrug-mediated tumor cell killing.
    Wiewrodt R; Amin K; Kiefer M; Jovanovic VP; Kapoor V; Force S; Chang M; Lanuti M; Black ME; Kaiser LR; Albelda SM
    Cancer Gene Ther; 2003 May; 10(5):353-64. PubMed ID: 12719705
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of the E1B 55 kDa gene product in oncolytic adenoviral vectors expressing herpes simplex virus-tk: assessment of antitumor efficacy and toxicity.
    Wildner O; Morris JC
    Cancer Res; 2000 Aug; 60(15):4167-74. PubMed ID: 10945625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic prodrug activation therapy (GPAT) in two rat prostate models generates an immune bystander effect and can be monitored by magnetic resonance techniques.
    Eaton JD; Perry MJ; Todryk SM; Mazucco RA; Kirby RS; Griffiths JR; Dalgleish AG
    Gene Ther; 2001 Apr; 8(7):557-67. PubMed ID: 11319623
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mapping of herpes simplex virus-1 VP22 functional domains for inter- and subcellular protein targeting.
    Aints A; Güven H; Gahrton G; Smith CI; Dilber MS
    Gene Ther; 2001 Jul; 8(14):1051-6. PubMed ID: 11526452
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular imaging with 123I-FIAU, 18F-FUdR, 18F-FET, and 18F-FDG for monitoring herpes simplex virus type 1 thymidine kinase and ganciclovir prodrug activation gene therapy of cancer.
    Wang HE; Yu HM; Liu RS; Lin M; Gelovani JG; Hwang JJ; Wei HJ; Deng WP
    J Nucl Med; 2006 Jul; 47(7):1161-71. PubMed ID: 16818951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
    Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
    J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Poor intercellular transport and absence of enhanced antiproliferative activity after non-viral gene transfer of VP22-P53 or P53-VP22 fusions into p53 null cell lines in vitro or in vivo.
    Zavaglia D; Lin EH; Guidetti M; Pluquet O; Hainaut P; Favrot MC; Coll JL
    J Gene Med; 2005 Jul; 7(7):936-44. PubMed ID: 15754307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined suicide gene and immunostimulatory gene therapy using AAV-mediated gene transfer to HPV-16 transformed mouse cell: decrease of oncogenicity and induction of protection.
    Janousková O; Síma P; Kunke D
    Int J Oncol; 2003 Mar; 22(3):569-77. PubMed ID: 12579310
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential cytotoxicity and bystander effect of the rabbit cytochrome P450 4B1 enzyme gene by two different prodrugs: implications for pharmacogene therapy.
    Frank S; Steffens S; Fischer U; Tlolko A; Rainov NG; Kramm CM
    Cancer Gene Ther; 2002 Feb; 9(2):178-88. PubMed ID: 11857036
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fusion of HSV-1 VP22 to a bifunctional chimeric SuperCD suicide gene compensates for low suicide gene transduction efficiencies.
    Lemken ML; Graepler F; Wolf C; Wybranietz WA; Smirnow I; Schmidt U; Gregor M; Bitzer M; Lauer UM
    Int J Oncol; 2007 May; 30(5):1153-61. PubMed ID: 17390017
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intercellular trafficking and enhanced in vivo antitumour activity of a non-virally delivered P27-VP22 fusion protein.
    Zavaglia D; Favrot MC; Eymin B; Tenaud C; Coll JL
    Gene Ther; 2003 Feb; 10(4):314-25. PubMed ID: 12595890
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suicide gene therapy of ovarian cancer: an experimental study in rats using retroviral-mediated transfer of herpes simplex virus thymidine kinase gene.
    Nagy HJ; Panis Y; Fabre M; Klatzmann D; Houssin D; Soubrane O
    Anticancer Res; 2000; 20(6B):4633-8. PubMed ID: 11205314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Vesicular stomatitis virus G-protein retrovector mediated a herpes simplex virus thymidine kinase gene transduction and expression in the human retinal pigment epithelial cells].
    Wang F; Wang HW; Lu DR; Xue JL; Zhang X
    Zhonghua Yan Ke Za Zhi; 2003 Apr; 39(4):201-5. PubMed ID: 12882696
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene therapy for endometrial carcinoma with the herpes simplex thymidine kinase gene.
    Ural AU; Takebe N; Adhikari D; Ercikan-Abali E; Banerjee D; Barakat R; Bertino JR
    Gynecol Oncol; 2000 Mar; 76(3):305-10. PubMed ID: 10684701
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced anti-tumor effects of herpes simplex virus thymidine kinase/ganciclovir system by codelivering monocyte chemoattractant protein-1 in hepatocellular carcinoma.
    Sakai Y; Kaneko S; Nakamoto Y; Kagaya T; Mukaida N; Kobayashi K
    Cancer Gene Ther; 2001 Oct; 8(10):695-704. PubMed ID: 11687892
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of bicistronic lentiviral vector-mediated herpes simplex virus thymidine kinase/ganciclovir system on human lens epithelial cells.
    Yang J; Liu TJ; Lu Y
    Curr Eye Res; 2007 Jan; 32(1):33-42. PubMed ID: 17364733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potentiation of ganciclovir toxicity in the herpes simplex virus thymidine kinase/ganciclovir administration system by ponicidin.
    Hayashi K; Hayashi T; Sun HD; Takeda Y
    Cancer Gene Ther; 2000 Jan; 7(1):45-52. PubMed ID: 10678355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.